These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 26577210)
1. Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation. Neelakantan IV; Di Palma S; Smith CE; McCoombe A Head Neck Pathol; 2016 Sep; 10(3):354-61. PubMed ID: 26577210 [TBL] [Abstract][Full Text] [Related]
2. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge. Ponti G; Manfredini M; Tomasi A; Pellacani G Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115 [TBL] [Abstract][Full Text] [Related]
3. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome. Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397 [TBL] [Abstract][Full Text] [Related]
4. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy. Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213 [TBL] [Abstract][Full Text] [Related]
5. [Muir-Torre syndrome and Turcot syndrome]. Velter C; Caussade P; Fricker JP; Cribier B Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262 [TBL] [Abstract][Full Text] [Related]
6. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report. Tomonari M; Shimada M; Nakada Y; Yamamoto I; Itoh M; Koike Y; Kobayashi A; Miki J; Yamada H; Kimura T; Saito S; Sugano K; Sekine S; Yamamoto H; Asahina A; Yokoo T BMC Nephrol; 2019 Oct; 20(1):394. PubMed ID: 31664942 [TBL] [Abstract][Full Text] [Related]
7. Muir-Torre Syndrome with Novel Mutation in the MSH2 Gene. Ustaoglu E; Agirgol S; Aymelek HS; Turhan EI Acta Dermatovenerol Croat; 2023 Dec; 31(3):144-147. PubMed ID: 38439724 [TBL] [Abstract][Full Text] [Related]
8. Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome. Simic D; Dummer R; Freiberger SN; Ramelyte E; Barysch MJ Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065301 [TBL] [Abstract][Full Text] [Related]
9. Germline Testing of Mismatch Repair Genes Is Needed in the Initial Evaluation of Patients With Muir-Torre Syndrome-Associated Cutaneous Sebaceous Neoplasms: A Case Series. Cohen PR; Kurzrock R Cureus; 2023 Jan; 15(1):e33975. PubMed ID: 36824550 [TBL] [Abstract][Full Text] [Related]
11. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Sebaceous Neoplasms for DNA Mismatch Repair Proteins in Muir-Torre Syndrome. Pollinger TH; Kieliszak CR; Logemann N; Gratrix ML Skinmed; 2017; 15(4):259-264. PubMed ID: 28859734 [TBL] [Abstract][Full Text] [Related]
13. Muir-Torre Syndrome in a Middle-Aged Chinese Patient with Sebaceous Carcinoma of the Eyelid. Wong CY; Tang RK; Lam RF; Io IY; Yuen CY; Ho JW; Tse RK Semin Ophthalmol; 2015; 30(5-6):420-2. PubMed ID: 24117411 [TBL] [Abstract][Full Text] [Related]
14. Patients with a new-onset cutaneous sebaceous neoplasm following immunosuppression should be evaluated for Muir-Torre syndrome with germline mismatch repair gene mutation analysis: case reports. Cohen PR; Kurzrock R Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762859 [TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal undifferentiated pleomorphic sarcoma having microsatellite instability associated with Muir-Torre syndrome: case report and review of literature. Lee N; Luthra R; Lopez-Terrada D; Wang WL; Lazar AJ J Cutan Pathol; 2013 Aug; 40(8):730-3. PubMed ID: 23672746 [TBL] [Abstract][Full Text] [Related]
16. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434 [TBL] [Abstract][Full Text] [Related]
17. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205 [TBL] [Abstract][Full Text] [Related]
19. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations. Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607 [TBL] [Abstract][Full Text] [Related]
20. [Muir-Torre syndrome--a phenotypic variant of Lynch syndrome]. Kacerovská D; Kazakov DV; Cerná K; Hadravský L; Michal M; Dostál J; Skálová A; Michal M Cesk Patol; 2010 Oct; 46(4):86-94. PubMed ID: 21313735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]